<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00173355</url>
  </required_header>
  <id_info>
    <org_study_id>9461700618</org_study_id>
    <nct_id>NCT00173355</nct_id>
  </id_info>
  <brief_title>Clinical Outcome of Pediatric Dermatofibrosarcoma Protuberans</brief_title>
  <official_title>Retrospective Clinical Outcome Study of Pediatric Dermatofibrosarcoma Protuberans: Single Institutional Experience of Twelve Cases From 1977-2002</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <brief_summary>
    <textblock>
      Retrospective review of clinical outcome of pediatric Dermatofibrosarcoma Protuberans (PDFSP)&#xD;
      after active invitation&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Soft tissue sarcoma was rarely seen in pediatric patients, and pediatric Dermatofibrosarcoma&#xD;
      Protuberans (PDFSP) was even rare. To our knowledge, the largest report constituted of 19&#xD;
      cases (five of them had no follow-up (FU) status) (1). So we proposed this retrospective&#xD;
      study based on the cancer registry of our hospital. Twelve cases who were diagnosed as DFSP&#xD;
      before age of 18 were identified. But all of them had been lost of FU for at least two years.&#xD;
      So we will try to contact these patients and asked them to be back to our clinic for routine&#xD;
      surveillance (history taking and physical exam and optional local image/chest xray) and&#xD;
      quality of life (QoL) evaluation after pathological review if this clinical study was&#xD;
      approved (2)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2005</start_date>
  <completion_date>August 2005</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Defined Population</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <enrollment>12</enrollment>
  <condition>Soft Tissue Neoplasms</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients diagnosed as DFSP before age of 18 after pathological review according to the&#xD;
             cancer registry of our hospital&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  age &gt; 18 at diagnosis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rong-Sen Yang, M.D., Ph.D.</last_name>
    <role>Study Chair</role>
    <affiliation>National Taiwan University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chun-Ru Chien, M.D.</last_name>
    <phone>886-2-23123456</phone>
    <phone_ext>2643</phone_ext>
    <email>stwo@ha.mc.ntu.edu.tw</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rong-Sen Yang, M.D, Ph.D</last_name>
    <phone>886-2-23516478</phone>
    <phone_ext>3958</phone_ext>
    <email>yang@ha.mc.ntu.edu.tw</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>100</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rong-Sen Yang, MD, PhD</last_name>
      <phone>886-23123456</phone>
      <phone_ext>3958</phone_ext>
      <email>yang@ha.mc.ntu.edu.tw</email>
    </contact>
    <contact_backup>
      <last_name>Chun-Ru Chien, M.D.</last_name>
      <phone>886-2-23516478</phone>
      <phone_ext>2643</phone_ext>
      <email>stwo@ha.mc.ntu.edu.tw</email>
    </contact_backup>
    <investigator>
      <last_name>Rong-Sen Yang, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>August 2005</verification_date>
  <study_first_submitted>September 12, 2005</study_first_submitted>
  <study_first_submitted_qc>September 12, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 15, 2005</study_first_posted>
  <last_update_submitted>November 23, 2005</last_update_submitted>
  <last_update_submitted_qc>November 23, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 24, 2005</last_update_posted>
  <keyword>pediatric Dermatofibrosarcoma Protuberans</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dermatofibrosarcoma</mesh_term>
    <mesh_term>Soft Tissue Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

